Glenmark Pharmaceuticals trades higher on the BSE

16 Mar 2020 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 219.75, up by 10.15 points or 4.84% from its previous closing of Rs. 209.60 on the BSE.

The scrip opened at Rs. 209.60 and has touched a high and low of Rs. 241.00 and Rs. 195.00 respectively. So far 278878 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 667.00 on 29-Mar-2019 and a 52 week low of Rs. 168.00 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 275.70 and Rs. 168.00 respectively. The current market cap of the company is Rs. 6334.68 crore.

The promoters holding in the company stood at 46.59%, while Institutions and Non-Institutions held 37.20% and 16.21% respectively.

Glenmark Pharmaceuticals’ Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Hikma Pharmaceuticals PLC (Hikma) for commercializing its novel nasal spray Ryaltris in the US. The agreement with Hikma is Glenmark’s fourth regional licensing deal for Ryaltris. Glenmark has already signed licensing deals for commercializing Ryaltris in China, Australia, New Zealand and South Korea.

Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltris by the US Food and Drug Administration (USFDA). Hikma will be responsible for the commercialization of Ryaltris in the US following approval. Hikma would also have the ability to produce the product utilizing its nasal manufacturing capabilities in Columbus, Ohio. Glenmark will receive an upfront payment, regulatory approval and commercial milestone payments as well as royalties from Hikma for Ryaltris.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

1962.20 -3.55 (-0.18%)
08-Dec-2025 11:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.30
Dr. Reddys Lab 1276.15
Cipla 1511.75
Zydus Lifesciences 932.75
Lupin 2089.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×